Covid-19 and alcohol associated liver disease

The COVID-19 pandemic is having substantial impacts on the health status of individuals with alcohol use disorder (AUD) and alcohol-associated liver disease (ALD). AUD and ALD have both been impacted throughout the pandemic, with increases in alcohol use during the early stages of the pandemic, reduced access to treatment during the mid-pandemic, and challenges in managing the downstream effects in the post-COVID era. This review will focus on how the COVID-19 pandemic has impacted AUD and ALD epi-demiology and access to treatment, and will discuss to address this rising AUD and ALD disease burden.(c) 2022 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Automated summary

The COVID-19 pandemic has had significant impacts on the health status of individuals with alcohol use disorder and alcohol-associated liver disease, including increased alcohol use, reduced access to treatment, and challenges in managing the downstream effects.